AKT has been proved to be an important initiator to induce EMT by increasing ZEB1 and ZEB2 expression [42], the subsequent inhibition of EMT can be reversed by IGF-I, suggesting that the activation of the PI3K/ AKT//ZEB2 pathway dominates the EMT development in GC cells [43]. This evidence concerns the gene ZEB2 and gastric cancer.